Androgen-dependent prostatic tumors: biosynthesis and possible actions of LHRH

[1]  D. MacGrogan,et al.  Expression of Nerve Growth Factor and Nerve Growth Factor Receptor Genes in Human Tissues and in Prostatic Adenocarcinoma Cell Lines , 1992, Journal of neurochemistry.

[2]  M. Motta,et al.  Antiproliferative effects of luteinizing hormone-releasing hormone agonists on the human prostatic cancer cell line LNCaP. , 1992, The Journal of clinical endocrinology and metabolism.

[3]  C. Knabbe,et al.  Regulation of fibroblast growth factor-like protein(s) in the androgen-responsive human prostate carcinoma cell line LNCaP , 1992, The Journal of Steroid Biochemistry and Molecular Biology.

[4]  A. MacDonald,et al.  Divergent responses to epidermal growth factor in hormone sensitive and insensitive human prostate cancer cell lines. , 1992, British Journal of Cancer.

[5]  K. Griffiths,et al.  Steroids and the prostate , 1991, The Journal of Steroid Biochemistry and Molecular Biology.

[6]  J. Veldscholte,et al.  Regulation of growth of LNCaP human prostate tumor cells by growth factors and steroid hormones , 1991, The Journal of Steroid Biochemistry and Molecular Biology.

[7]  C. Knabbe,et al.  Growth factors in human prostate cancer cells: Implications for an improved treatment of prostate cancer , 1991, The Journal of Steroid Biochemistry and Molecular Biology.

[8]  J. Mendelsohn,et al.  Autonomous growth of androgen-independent human prostatic carcinoma cells: role of transforming growth factor alpha. , 1991, Cancer research.

[9]  R. Gittes.  Carcinoma of the prostate. , 1991, The New England journal of medicine.

[10]  W. Gullick,et al.  The partial purification and characterization of GnRH-like activity from prostatic biopsy specimens and prostatic cancer cell lines , 1990, The Journal of Steroid Biochemistry and Molecular Biology.

[11]  G. Jenster,et al.  A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens. , 1990, Biochemical and biophysical research communications.

[12]  K. Sikora,et al.  The effects of gonadotrophin releasing hormone analogues in prostate cancer are mediated through specific tumour receptors. , 1990, British Journal of Cancer.

[13]  N. Olea,et al.  Negative controls of cell proliferation: human prostate cancer cells and androgens. , 1989, Cancer research.

[14]  J. Griffin,et al.  Expression of the M-CSF (CSF-1) gene by human monocytes. , 1987, Blood.

[15]  W I Wood,et al.  Base composition-independent hybridization in tetramethylammonium chloride: a method for oligonucleotide screening of highly complex gene libraries. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[16]  G. Murphy,et al.  LNCaP model of human prostatic carcinoma. , 1983, Cancer research.

[17]  B. Horsthemke,et al.  Degradation of luteinizing hormone - releasing hormone and analogs by adenohypophyseal peptidases. , 1981, Biochemical and biophysical research communications.

[18]  G. Niswender,et al.  Serum levels of luteinizing hormone and gonadotropin-releasing hormone in cycling, castrated and anestrous ewes. , 1974, Endocrinology.

[19]  S. Nilsson.  [Hormone therapy of prostatic cancer]. , 1968, Lakartidningen.

[20]  H. Klocker,et al.  DNA sequence of the androgen receptor in prostatic tumor cell lines and tissue specimens assessed by means of the polymerase chain reaction , 1993, The Prostate.

[21]  G. Wilding.  The importance of steroid hormones in prostate cancer. , 1992, Cancer surveys.

[22]  D. Rose,et al.  Autocrine regulation of DU145 human prostate cancer cell growth by epidermal growth factor‐related polypeptides , 1991, The Prostate.

[23]  F. Schröder,et al.  Endocrine therapy: where do we stand and where are we going? , 1991, Cancer surveys.

[24]  D. Rose,et al.  Production of epidermal growth factor and transforming growth factor‐α by the androgen‐responsive LNCaP human prostate cancer cell line , 1990, The Prostate.

[25]  E. Gelmann,et al.  Role of transforming growth factor ‐α in human prostate cancer cell growth , 1989 .

[26]  A. Schuurmans,et al.  Androgen receptor-mediated growth and epidermal growth factor receptor induction in the human prostate cell line LNCaP. , 1989, Urologia internationalis.

[27]  P. Seeburg,et al.  Isolation of the gene and hypothalamic cDNA for the common precursor of gonadotropin-releasing hormone and prolactin release-inhibiting factor in human and rat. , 1986, Proceedings of the National Academy of Sciences of the United States of America.